Press releases | Finanzwire

Basculer en Français

9476	Companies
185464	Keywords
117811	Articles
99314	Press releases

Home
Press releases

PRESS RELEASE

published on 12/04/2025 at 20:15, 18 hours ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Galimedix Therapeutics presents compelling Phase 1 study results at CTAD 2025, demonstrating excellent safety and pharmacokinetics of GAL-101, planning Phase 2 study in Alzheimer's disease

Alzheimer's Disease Galimedix Therapeutics GAL-101 Phase 1 Study CTAD 2025
PRESS RELEASE

published on 12/04/2025 at 19:30, 18 hours 45 minutes ago

SMX: How a Single Counterfeit Bar Could Trigger a Multibillion-Dollar Panic
SMX introduces molecular identity technology to enhance gold market security, eliminate counterfeits, and ensure trustworthy bullion authentication amidst global uncertainties

Gold Market SMX Counterfeits Molecular Identity Technology Bullion Authentication
PRESS RELEASE

published on 12/04/2025 at 19:13, 19 hours 2 minutes ago

Inside Information / Other news releases
Press release regarding the number of outstanding shares and voting rights of a Société Anonyme in Paris as of November 30, 2025

Voting Rights Société Anonyme Outstanding Shares Paris General Meeting
PRESS RELEASE

published on 12/04/2025 at 19:10, 19 hours 5 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
SCHOTT Pharma's preliminary results for fiscal year 2025 show revenue growth and increased EBITDA margin. Outlook for FY 2026 includes moderate revenue growth and mid-term guidance updates towards 30% EBITDA margin by 2029

Revenue Growth EBITDA Margin SCHOTT Pharma Fiscal Year 2025 Mid-term Guidance
PRESS RELEASE

published on 12/04/2025 at 18:53, 19 hours 22 minutes ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance
SCHOTT Pharma AG & Co. KGaA issues fiscal year 2026 outlook and updates mid-term guidance, projecting revenue growth of 2-5% and EBITDA margin around 27%. Market expectations differ

Revenue Growth Financial Guidance EBITDA Margin SCHOTT Pharma Fiscal Year 2026
PRESS RELEASE

published on 12/04/2025 at 18:50, 19 hours 25 minutes ago

Start-up of the first deep well dedicated to Natural Hydrogen EUR 8.8m in funding grants secured for the project
Start-up of the first deep well dedicated to Natural Hydrogen by FDE in Moselle, France, under REGALOR II program supported by Grand Est Region and EU, securing €8.8m grants

EU Funding FDE Natural Hydrogen Grand Est Region REGALOR II
PRESS RELEASE

published on 12/04/2025 at 18:35, 19 hours 40 minutes ago

Showroomprivé announces the signing of an agreement to sell The Bradery
Showroomprivé announces the sale of its stake in Symmetric SAS, owner of The Bradery brand, to its two executives. Payment upon closing, vendor loan, and transaction details included

Sale Transaction Showroomprivé The Bradery Symmetric SAS
PRESS RELEASE

published on 12/04/2025 at 18:30, 19 hours 45 minutes ago

Total number of shares and voting rights at November 30, 2025
Orange provides information on total shares, voting rights, and double voting rights for shareholders in compliance with French Commercial Code regulations

Voting Rights French Commercial Code Shares Orange Double Voting Rights
PRESS RELEASE

published on 12/04/2025 at 18:24, 19 hours 51 minutes ago

POS-Transaction in Own Shares
Funding Circle Holdings plc has purchased 60,281 Ordinary Shares from Investec Bank plc, with a volume weighted average price of 124.7019p per share, holding a total of 1,667,954 shares in treasury

London Stock Exchange Ordinary Shares Treasury Shares Funding Circle Holdings PLC Investec Bank Plc
PRESS RELEASE

published on 12/04/2025 at 18:21, 19 hours 54 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Fuller, Smith & Turner PLC announces the purchase of 1,296 'A' Ordinary Shares as part of its share buyback programme

London Stock Exchange Share Buyback Programme Fuller Smith Turner PLC Own Shares Transaction

Accesswire

Published on 12/05/2025 at 14:00, 15 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 15 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 11 hours 40 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 11 hours 45 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 15 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:45, 30 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 15 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 1 hour 15 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 2 hours 10 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 2 hours 15 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre

Les Echos

Published on 12/05/2025 at 08:45, 5 hours 30 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 15 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 20 hours 30 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 20 hours 31 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE